Blue Trust Inc’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-731
Closed -$74.2K 2572
2025
Q4
$74.2K Sell
731
-817
-53% -$65.6K ﹤0.01% 1199
2025
Q3
$84.7K Buy
1,548
+418
+37% +$20.9K ﹤0.01% 1147
2025
Q2
$60K Sell
1,130
-18
-2% -$914 ﹤0.01% 1290
2025
Q1
$49.7K Buy
1,148
+17
+2% +$861 ﹤0.01% 1368
2024
Q4
$63.6K Sell
1,131
-4,089
-78% -$254K ﹤0.01% 1140
2024
Q3
$221K Buy
5,220
+1,978
+61% +$112K ﹤0.01% 812
2024
Q2
$224K Buy
3,242
+3,193
+6,516% +$176K ﹤0.01% 660
2024
Q1
$3.38K Sell
49
-1,243
-96% -$78.6K ﹤0.01% 1710
2023
Q4
$88K Buy
+1,292
New +$84.7K ﹤0.01% 730
2023
Q2
Sell
-191
Closed -$9K 2168
2023
Q1
$9K Buy
191
+10
+6% +$643 ﹤0.01% 1625
2022
Q4
$6K Sell
181
-1,177
-87% -$48.1K ﹤0.01% 1664
2022
Q3
$53K Buy
1,358
+53
+4% +$2.19K ﹤0.01% 732
2022
Q2
$91K Buy
+1,305
New +$69.8K ﹤0.01% 524

Other funds holding EXAS

Blue Trust Inc's EXAS Position: Q1 2026 in Review

Blue Trust Inc sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 731 shares — an estimated $74.2K sold.

Blue Trust Inc first reported a position in EXAS in Q2 2022 and held it in 13 quarters. The position peaked at $224K in Q2 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Blue Trust Inc reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Blue Trust Inc sold 731 Exact Sciences shares in Q1 2026, an estimated $74.2K.
  • Blue Trust Inc first reported a position in Exact Sciences in Q2 2022 and held it in 13 quarters.
  • Blue Trust Inc's Exact Sciences position peaked at $224K in Q2 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.